Cencora, Inc. (formerly AmerisourceBergen Corporation) - 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on January 6, 2003, reporting events occurring on January 3, 2003. The filing details the closing of a strategic acquisition to expand the company's healthcare technology portfolio.
Key Financial Metrics and Transaction Details
The filing does not provide consolidated revenue, profit, cash flow, or margin data for the reporting period. The primary financial disclosure relates to the acquisition of Bridge Medical, Inc.:
- Base Purchase Price: $27 million.
- Contingent Consideration: Up to $55 million, payable if earnings targets are met in calendar years 2003 and 2004.
- Payment Structure: Approximately 15% of the base price paid in cash; the balance paid via issuance of 401,780 shares of common stock.
- Escrow Arrangement: An additional 401,780 shares were issued into an escrow account to cover potential future contingent payments.
Material Changes
The material change reported is the successful closing of the acquisition of Bridge Medical, Inc., a leading provider of barcode-enabled point-of-care (BPOC) software. This transaction adds capabilities designed to reduce medication errors and decrease costs in healthcare facilities to the Company's offerings.
Outlook, Risks, and Contingencies
Future financial obligations are contingent upon Bridge Medical achieving specific earnings targets in 2003 and 2004. The final number of shares issued for contingent payments will depend on:
- Whether the applicable earnings targets are met.
- The per-share trading price of the Company's common stock at the time payments become due.
The Company expects to retire any excess shares remaining in the escrow account after the contingent payment determinations are finalized.
Key Facts for Investor Verification
- Verify the total consideration paid ($27 million base + potential $55 million contingent) against the company's cash reserves and stock dilution impact.
- Monitor Bridge Medical's performance in 2003 and 2004 to determine if the $55 million contingent payment will be triggered.
- Confirm the final number of shares issued from the escrow account once the contingent payment period concludes.
- Review the integration progress of Bridge Medical's BPOC software into the Company's existing operations.